Expression of BLIMP1, a marker of plasmacytic differentiation that is commonly inactivated in ABC-DLBCL, did not correlate with patient outcome or FOXP2 expression in this series. The gene discussed is FOXP2; the disease is diffuse large B-cell lymphoma.